Ileostomy Market Size & Share 2026-2035

Ileostomy Market Size

The global ileostomy market was estimated at USD 1.3 billion in 2025. The market is expected to grow from USD 1.4 billion in 2026 to USD 2.1 billion in 2035, at a CAGR of 4.9% during the forecast period, according to the latest report published by Global Market Insights Inc.

The market is driven by several factors, including the increasing prevalence of inflammatory bowel diseases, a growing focus on awareness programs coupled with favorable reimbursement scenarios, technological advancements in ostomy products, an aging population, and a rise in surgical interventions, among other factors.

Shift toward minimally invasive surgeries, expansion of home healthcare settings, and healthcare infrastructure are expected to fuel the industry's growth. Coloplast, ConvaTec Group, Hollister, B. Braun, and Smith+Nephew are among the leading players operating in the market. These players mainly focus on product innovation, geographic expansion, the use of novel materials, strong R&D, and collaboration with local or regional healthcare providers, among other factors.

The market has increased from USD 1.1 billion in 2022 and reached USD 1.2 billion in 2024, with a historic growth rate of 7.6%. Surgical interventions, including ileostomies, are becoming more common due to rising cases of colorectal cancer and gastrointestinal complications. According to the data reported by the World Cancer Research Fund, there were 1.9 million new cases of colorectal cancer in 2022 globally. With improvements in surgical techniques and access to healthcare facilities, more patients are undergoing these procedures, increasing the demand for post-operative care products like ostomy bags and accessories.

Additionally, in developed countries, favorable reimbursement policies for ostomy care products have increased affordability for patients. Comprehensive coverage for ostomy bags, skin barriers, and accessories by insurance providers encourages the adoption of these products and fuels market growth. Moreover, with increasing emphasis on minimally invasive procedures and palliative care for chronic conditions, ileostomy care products are becoming an integral part of patient management. These products ensure comfort and convenience for patients undergoing long-term ostomy care.

An ileostomy is a surgical procedure in which a portion of the small intestine (ileum) is brought to the surface of the abdomen to create an opening called a stoma. This allows waste material to bypass the colon, rectum, and anus, exiting the body through the stoma into an external pouch or ostomy bag.

Ileostomy Market Trends

Expansion of home healthcare and self-care adoption, advancements in skin protection and peristomal care, increased awareness and normalization of ostomy care, and patient-centric product design and comfort optimization are among the key trends shaping the market growth.

• Modern ostomy bags have evolved significantly to enhance efficiency and user comfort. Features such as odor-proof and leak-resistant systems, flexible and skin-friendly adhesives, customizable designs, and integrated ventilation with charcoal filters are key innovations driving improved patient satisfaction and quality of life.
• Additionally, devices with integrated sensors enhance user convenience by monitoring bag fill levels and sending alerts via mobile apps to prevent overflows. Advanced systems also track usage patterns and skin health, offering valuable insights for users and healthcare providers to improve management and care.
• Further, advances in 3D printing technology enable the creation of customized ostomy appliances tailored to individual anatomical needs. This innovation significantly enhances comfort, fitness, and effectiveness, particularly for patients with unique or complex requirements.

Ileostomy Market Analysis

Based on type, the market is segmented as end ileostomy, loop ileostomy and other types. The end ileostomy segment accounted for a majority share of 57.5% in 2025. Product innovation focused on comfort and leakage prevention is anticipated to fuel the segmental growth. The segment is expected to reach USD 1.2 billion by 2035, growing at a CAGR of 5.2% during the forecast period.

• Laparoscopic and robotic-assisted surgeries have made end ileostomy procedures less invasive, reducing recovery times and increasing acceptance among patients. Easier recovery has encouraged more patients and healthcare providers to opt for end ileostomies, particularly in cases requiring permanent solutions.
• End ileostomies are often chosen for their durability and lower complication rates compared to temporary loop ileostomies. This preference is particularly strong among patients with severe conditions or after failed restorative procedures.
• In addition, innovations in stoma care products, such as odor-resistant bags, skin-friendly adhesives, and discreet designs, have made living with an end ileostomy more manageable.
• The loop ileostomy segment was valued at USD 405.8 million in 2025. A loop ileostomy is often created temporarily to divert bowel contents while healing occurs following colorectal surgery. Compared to an end ileostomy, loop ileostomy procedures are more frequently performed and have a shorter time frame.
• Further, the significant number of surgeries performed ensures ongoing use and demand for entry-level and mid-priced ostomy products. Features such as ease of use, reliable adhesion, and skin protection following surgery are important in this segment.

Based on product, the ileostomy market is segmented as ostomy bags and accessories. The ostomy bags segment generated the highest revenue of USD 1.1 billion in 2025.

• The demand for ostomy bags has been steadily increasing due to their critical role in managing waste elimination for individuals with ileostomies, colostomies, or urostomies. These bags are essential for patients post-surgery and are pivotal in improving quality of life.
• In addition, the increasing incidence of conditions such as colorectal cancer, Crohn’s disease, ulcerative colitis, and diverticulitis drives the demand for ostomy surgeries, directly impacting the need for ostomy bags.
• Furthermore, ostomy bags are indispensable post-surgery for waste collection. The growing number of ileostomy and colostomy procedures has increased their usage. Both short-term (loop ostomies) and long-term (end ostomies) patients rely on these products.
• The accessories segment was valued at USD 220.7 million in 2025. Accessories include skin barriers, adhesive removers, protective wipes, belts, and deodorants. This segment plays a crucial role in improving skin health and reducing complications.
• Accessories often complement pouching systems and drive incremental revenue.
• Rising awareness of peristomal skin management is strengthening demand, especially among long-term ileostomy patients and home care users seeking enhanced comfort and protection.

Based on application, the ileostomy market is segmented as colorectal cancer, ulcerative colitis, crohn's disease, and other applications. The colorectal cancer segment is expected to drive business growth and expand at a CAGR of 5.2%.

• Increased adoption of colorectal cancer screening programs in developed and emerging markets has led to early-stage diagnoses, driving surgical intervention rates and subsequent ostomy requirements. The risk of colorectal cancer increases significantly with age, with most diagnoses occurring in individuals aged 50 and above. As per the statistics by WCRF International, there were over 160 thousand new cases of colorectal cancer in the U.S. in 2022.
• Moreover, the availability of patient support groups and resources for colorectal cancer survivors is promoting acceptance of ostomy products. Programs emphasizing post-cancer rehabilitation include ileostomy care as a critical component, boosting demand.
• The ulcerative colitis segment was valued at USD 333.7 million in 2025. Ulcerative colitis drives ileostomy demand in severe or treatment-resistant cases.
• Patients are often younger and more lifestyle-conscious, increasing preference for discreet, flexible, and low-profile systems.
• Additionally, long-term disease management contributes to recurring product demand and higher emphasis on comfort and skin-friendly solutions.

• Hospitals represent a critical end-use segment in the market, as most ileostomy procedures originate in acute and tertiary care settings. Demand in this segment is driven by preoperative planning, post-surgical recovery, and standardized clinical protocols.
• Hospitals prioritize products that offer reliable adhesion, ease of application, and compatibility with short-term post-operative care.
• In addition, purchasing decisions are often influenced by procurement contracts, cost efficiency, and clinician familiarity. The initial product selected during hospitalization frequently shapes long-term patient usage once discharged, giving hospitals a strong influence over brand adoption and continuity into home care.
• The home care settings segment was valued at USD 501.9 million in 2025. The rise of telemedicine provides an avenue for patients to receive consultations from ostomy care specialists without leaving their homes. Virtual support groups also play a key role in patient confidence, promoting better care practices.
• Further, home care is often a more affordable alternative to hospitalization or long-term care facilities, which is a key factor in driving the growth of this segment.
• Many patients prefer receiving care at home as it is more comfortable and familiar. The move to home healthcare has been increasingly popular in the last few years, particularly with chronic conditions such as colorectal cancer, Crohn’s disease, and ulcerative colitis.

North America Ileostomy Market

The North America market accounted for notable share of 19.3% in 2025 and is anticipated to show notable growth over the forecast period.

• The U.S. market was valued at USD 237.7 million in 2025, up from USD 228.4 million in 2024. Innovation in eco-friendly ostomy products coupled with strategic partnerships with hospitals and clinics are among the key factors fueling the industry growth.
• Additionally, the U.S. has one of the highest rates of colorectal cancer in the world. For instance, as per the data reported by The Centers for Disease Control and Prevention, around 52,967 people died from colorectal cancer in 2022. Many of these patients undergo colectomy surgeries, leading to an increased need for ileostomy and colostomy care products. Many elderly individuals live with chronic conditions that necessitate long-term ostomy care, contributing to the market growth.
• Moreover, conditions such as Crohn’s disease and ulcerative colitis are prevalent in the U.S., both of which often require ileostomy surgeries. The increasing rates of these diseases further contribute to the growing demand for ostomy products.

Europe Ileostomy Market

Europe accounted for a leading share of the global market and was valued at USD 461.2 million in 2025.

• The market in Europe is well-established and continues to demonstrate exceptional growth due to both an aging population and a strong focus on improving quality of life for patients after surgery.
• Many European nations have universal health care systems that promote continuous access to ostomy products, which continue to generate long-term demand for these products.
• In addition to universal health care, the standard of care is very high in Europe, with the early detection of gastrointestinal diseases and structured follow-up care programs, all contributing to continued growth in the market for ostomy products.
• Additionally, European consumers show a strong preference for comfort, sustainability, and skin protection, encouraging manufacturers to introduce advanced barrier materials and eco-conscious products.

Asia Pacific Ileostomy Market

The Asia Pacific market accounted for a significant share of the market and was valued at USD 425.8 million in 2025.

• The market is experiencing rapid expansion in the Asia Pacific region due to rising numbers of surgeries being performed, an increase in awareness about gastrointestinal issues, and continued growth in overall healthcare infrastructure across the region.
• Urbanization, improved access to insurance coverage, and increased acceptance of newer technologies in healthcare are all contributing to faster adoption rates of ileostomy products in countries such as China, India, and Southeast Asia.
• Affordability continues to play an important role in the growing demand for high-quality ostomy products. Additionally, with the increasing survival rates for patients diagnosed with colorectal cancers and a gradual decrease in social stigma surrounding the performance of ostomy procedures, manufacturers also have a greater opportunity for continued market growth within this region.

Latin America Ileostomy Market

The Latin American market is anticipated to exhibit remarkable growth during the analysis period.

• Ileostomy industry in Latin America is expanding at a robust pace and is gaining support through the improved availability of surgical treatment and an increase in the number of people diagnosed with colorectal cancer.
• Public healthcare systems drive volumes, while private hospitals contribute demand for premium products. Urban centers lead to adoption due to better specialist availability and patient education.
• Further, efforts to improve awareness of stoma care and post-operative management are playing a critical role in strengthening long-term product utilization.

Middle East and Africa Ileostomy Market

The Middle East and Africa market is expected to experience substantial growth over the analysis timeframe.

• The MEA market is continuing to develop at a steady rate, primarily due to the advanced healthcare systems of the Gulf Cooperation Council (GCC) countries in the Middle East.
• In addition, government funding for hospitals and expanding cancer treatment options, as well as medical tourism, increases demand in these countries.
• Further, growth is supported by increasing focus on post-surgical care standards and gradual expansion of insurance coverage.
• Global manufacturers typically operate through distributors, targeting tertiary hospitals and private clinics.

Ileostomy Market Share

The market is a fairly mature and consolidated sector comprised primarily of multinational medical device manufacturers with good brand recognition, excellent clinical relationships, and well-developed distribution channels. Price competition is less of a factor than product dependability, skin compatibility, patient comfort, and long-term user compliance.

The major companies in this industry, such as Coloplast, ConvaTec, and Hollister, primarily compete via ongoing incremental innovations to provide customers with advanced barrier materials, as well as develop improved ways to prevent leaks and odors and provide discreet products that can be used to improve the quality of life for the user. All the leading companies have invested considerably in patient education, nurse-led education programs, and clinical support services to improve products and build long-term customer loyalty through high switching costs.

Additionally, key players in the market are focused on innovation, geographic expansion, and enhancing patient-centric solutions. They are investing in R&D to develop advanced ostomy bags with features like odor control, skin-friendly adhesives, and discreet designs. Companies are expanding their presence in emerging markets to tap into growing demand. Collaborations with healthcare providers and educational initiatives are being emphasized to increase awareness about ostomy care.

Further, various players are introducing customized solutions and offering home delivery services to enhance convenience for patients. Moreover, sustainability is also a key focus, with efforts to create eco-friendly ostomy products gaining traction.

Ileostomy Market Companies

A few of the prominent players operating in the global ileostomy industry include:

• Alcare
• B. Braun
• Coloplast
• ConvaTec Group
• Cymed Micro Skin
• Flexicare
• Hollister
• Marlen Healthcare
• Nu-Hope Labs
• Safe n Simple
• Salts Healthcare
• Smith+Nephew
• Torbot Group
• Welland Medical
• Unora Healthcare

• Coloplast

Focuses on patient-centric innovation in ostomy systems, premium skin-friendly materials, strong clinical education programs, and direct-to-consumer engagement to build brand loyalty and expand presence in developed and emerging markets.

• Hollister

Centers strategy on reliability and simplicity of pouching systems, nurse-led education, conservative innovation cycles, and strong reimbursement alignment to retain long-term users and institutional contracts.

• B. Braun

Leverages integrated healthcare portfolio, cost-efficient manufacturing, and hospital-centric sales model, positioning ostomy products within broader surgical and post-operative care offerings to strengthen system-wide adoption globally sustained.

Ileostomy Industry News

• In July 2025, global medical device manufacturer Eakin Healthcare launched the world’s largest ostomy bag production line, marking a major milestone in its USD 11.9 million investment at its Cardiff Business Park site. This launch is part of an overall USD 79.1 million investment and transformation program by the company in the UK.
• In May 2024, Coloplast A/S strengthened its ostomy care product portfolio with three product launches, including the Heylo (the world's first digital leakage notification system), SenSuraMio Black and SenSura Mio Convex Soft with Flex coupling. This significant development will expand its product range and further consolidate its industry position.

The ileostomy market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• End ileostomy
• Loop ileostomy
• Other types

Market, By Product

• Ostomy bags
  • Two-piece bags
  • One-piece bags
• Accessories

Market, By Application

• Colorectal cancer
• Ulcerative colitis      
• Crohn's disease       
• Other applications

Market, By End Use

• Home care settings
• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE